Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Counter

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Nature|April 11, 2014
Copper is required for oncogenic BRAF signalling and tumorigenesisDonita C Brady, Matthew S Crowe, Michelle L Turski, et al.
Nature Cell Biology|March 30, 2004
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cellsElizabeth Yeh, Melissa Cunningham, Hugh Arnold, et al.
JCI Insight|June 8, 2018
Wild-type Kras expands and exhausts hematopoietic stem cellsJoshua P Sasine, Heather A Himburg, Christina M Termini, et al.
Plos One|July 2, 2015
A Genetic Porcine Model of CancerLawrence B Schook, Tiago V Collares, Wenping Hu, et al.
Cancer Research|June 29, 2012
Targeting eNOS in pancreatic cancerBenjamin L Lampson, S Disean Kendall, Brooke B Ancrile, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar RhabdomyosarcomaSusu Zhang, Kathleen Engel, Assil Fahs, et al.
Cancer Research|January 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor MicroenvironmentRachel A Burge, Ozgun Le Roux, Olesja Popow, et al.
Cell Reports|December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatmentJennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Nature|April 11, 2014
Copper is required for oncogenic BRAF signalling and tumorigenesisDonita C Brady, Matthew S Crowe, Michelle L Turski, et al.
Nature Cell Biology|March 30, 2004
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cellsElizabeth Yeh, Melissa Cunningham, Hugh Arnold, et al.
JCI Insight|June 8, 2018
Wild-type Kras expands and exhausts hematopoietic stem cellsJoshua P Sasine, Heather A Himburg, Christina M Termini, et al.
Plos One|July 2, 2015
A Genetic Porcine Model of CancerLawrence B Schook, Tiago V Collares, Wenping Hu, et al.
Cancer Research|June 29, 2012
Targeting eNOS in pancreatic cancerBenjamin L Lampson, S Disean Kendall, Brooke B Ancrile, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar RhabdomyosarcomaSusu Zhang, Kathleen Engel, Assil Fahs, et al.
Cancer Research|January 20, 2026
KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor MicroenvironmentRachel A Burge, Ozgun Le Roux, Olesja Popow, et al.
Cell Reports|December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatmentJennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Pageof 9